[Form 4] TeraWulf Inc. Insider Trading Activity

Rhea-AI Filing Summary

A director of TeraWulf Inc. sold shares on 08/15/2025. Amanda Fabiano, listed as a director, disposed of 4,600 shares of TeraWulf common stock at a reported price of $8.64 per share, leaving her with 40,769 shares beneficially owned after the transaction. The Form 4 indicates no derivative transactions and was signed by an attorney-in-fact on 08/18/2025. The filing shows the sale was reported individually by the reporting person and includes no details on the reason for the sale or any trading plan.

Positive

• Timely disclosure of insider transaction via Form 4, with signature by attorney-in-fact
• No derivative transactions reported alongside the sale, simplifying ownership picture

Negative

• Insider sale of 4,600 shares at $8.64 per share by a company director
• Limited context: the form does not state a trading plan or reason for the disposal

Insights

Financial Analyst

TL;DR: A director executed a small open-market sale of common stock; filing is routine disclosure without additional context.

The Form 4 reports a single non-derivative sale of 4,600 shares at $8.64, leaving 40,769 shares beneficially owned. This is a straightforward disclosure of an insider sale; there are no derivative instruments, no 10b5-1 plan referenced on the face of the form, and no additional quantitative context such as dollar value of remaining holdings. The filing does not provide information about the purpose of the sale or any change in role at the company, so its material impact on valuation cannot be assessed from this document alone.

Corporate Governance Expert

TL;DR: The filing documents required insider reporting for a director sale; there is no evidence of governance change or material event.

The document shows compliance with Section 16 reporting: a director sold 4,600 shares and the Form 4 was signed by an authorized attorney-in-fact. The record contains no indication of a pledge, options exercise, or other related-party transaction. Because the filing lacks explanatory detail, it does not by itself indicate governance issues or a material corporate development.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fabiano Amanda

(Last) (First) (Middle)

C/O TERAWULF INC.

9 FEDERAL STREET

(Street)

EASTON MD 21601

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TERAWULF INC. [ WULF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, $0.001 par value per share	08/15/2025		S		4,600	D	$8.64	40,769	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Stefanie C. Fleischmann, as attorney-in-fact for Amanda Fabiano	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Amanda Fabiano report in the Form 4 for WULF?

The Form 4 reports that Amanda Fabiano, a director, disposed of 4,600 shares of TeraWulf common stock on 08/15/2025 at a reported price of $8.64 per share, leaving 40,769 shares beneficially owned.

Does the Form 4 show any option exercises or derivative transactions for WULF?

No. Table II for derivative securities is empty and the filing lists only a non-derivative sale of common stock.

Was the Form 4 filed jointly or by one reporting person for WULF?

The form indicates it was filed by one reporting person.

Is there a 10b5-1 plan or reason for the sale disclosed in the filing?

The filing does not indicate a 10b5-1 plan nor provide a reason for the sale.

When was the Form 4 signed and by whom?

The Form 4 was signed on 08/18/2025 by Stefanie C. Fleischmann, as attorney-in-fact for Amanda Fabiano.